Simplex Trading’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Simplex Trading’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-121	Closed	–	–	10599
2020 Q4	$0	Buy	+121	New	+$1.53K	﹤0.01%	9443

Simplex Trading's PRVL Position: Q1 2021 in Review

Simplex Trading sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 121 shares.

Simplex Trading first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Simplex Trading reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Simplex Trading sold 121 Prevail Therapeutics Inc. Common Stock shares in Q1 2021.
Simplex Trading first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Simplex Trading's Prevail Therapeutics Inc. Common Stock position peaked at $0 in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.